Skip to main content
Log in

A model of a code of ethics for tissue banks operating in developing countries

  • Original paper
  • Published:
Cell and Tissue Banking Aims and scope Submit manuscript

Abstract

Ethical practice in the field of tissue banking requires the setting of principles, the identification of possible deviations and the establishment of mechanisms that will detect and hinder abuses that may occur during the procurement, processing and distribution of tissues for transplantation. This model of a Code of Ethics has been prepared with the purpose of being used for the elaboration of a Code of Ethics for tissue banks operating in the Latin American and the Caribbean, Asia and the Pacific and the African regions in order to guide the day-to-day operation of these banks. The purpose of this model of Code of Ethics is to assist interested tissue banks in the preparation of their own Code of Ethics towards ensuring that the tissue bank staff support with their actions the mission and values associated with tissue banking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. International Ethical Guidelines for Biomedical Research Involving Human Subjects, the Council for International Organisations of Medical Sciences (CIOMS) in collaboration with the World Health Organisation (WHO), Geneva 2002

  2. According to the Declaration of Istanbul, all countries need a legal and professional framework to govern tissue donation and transplantation activities, as well as a transparent regulatory oversight system that ensures donor and recipient safety and the enforcement of standards and prohibitions of unethical practices.

  3. Tissues for transplantation should be equitably allocated within countries or jurisdictions to suitable recipients without regard to gender, ethnicity, religion or social or financial status. Financial considerations or material gain of any party must not influence the application of relevant allocation rules.

  4. For this reason, all promotional activities related to tissue donations should be carried out by the tissue bank respecting all national regulations in force with the purpose of ensuring that the tissue donation will be obtained in a manner that unethical practices are totally excluded.

  5. It is important to single out, in the case of living donors, the following: The ethical issues associated with the donation of human tissues for transplantation from a living donor principally involve concern for the donor: The autonomy and welfare of the donor takes precedence over the needs of the recipient to receive a human tissue.

  6. All States of the EU adhere to the ethical principle that donation of human tissues must be free, and this rule out any payment to the donor. However, the donor may receive compensation for the constraints associated with tissue removal (e.g., travel expenses, loss of earnings, etc.).

  7. Retaliation means harm done to persons in retribution for raising concerns in good faith or violations of the Code of Ethics or any other of the tissue bank’s policy and regulations.

  8. A person is closely related to the tissue bank staff by blood or marriage if they are mother, father, brother, sister, son, daughter, father-in-law, mother-in-law, son-in-law, daughter-in-law, sister-in-law, brother-in-law, grandmother, grandfather, grandson, granddaughter, uncle, aunt, nephew, niece, husband, wife, step-parent, step-child, step-brother, step-sister, guardian or ward.

  9. The term “gift” includes any cash, gratuity, favour, discount, entertainment, admission to sporting and cultural events, hospitality, loan or any other benefit or item having monetary value. Such benefits include services and/or gifts of training, transportation, travel, lodgings and meals, whether provided in-kind, by purchase of a ticket, payment in advance or reimbursement after the expense has been incurred.

References

  • Bauer K, Taub S, Parsi K (2004) Ethical issues in tissue banking for research: a brief review of existing organisational policies. Theor Med Bioeth

  • Code of Ethical Principles and Conduct (2001) PAHO directing council (CD46/28). Washington DC, USA

  • Davenport J (1997) Ethical principles in clinical practices. Perm J, Portland, USA

  • Ethical Principles for Medical Research Involving Human Subjects (2008) World medical association declaration of Helsinki, 59th WMA general assembly, Seoul, Republic of Korea, October 2008

  • Ethical Principles for Medical Research Involving Human Subjects (2000) Declaration of Helsinki, World Medical Association, Adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975, 35th WMA General Assembly, Venice, Italy, October 1983, 41st WMA General Assembly, Hong Kong, September 1989, 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996, and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000

  • Ethics, access and safety in tissue and organ transplantation: issues of global concern (2003) WHO’s report, World Health Organisation, Madrid, Spain, October 2003

  • Ethics and the exchange, sale of and profit from products derived from human tissue (2009) National Health and Medical Research Council, Canberra, Australia, April 2009

  • Gassner UM (2007) Legal aspects of tissue banking. Faculty of Law, University of Augsburg, Augsburg, Germany. Pathobiology J

  • Human tissue: ethical and legal issue (1995) Nuffield Council of Bioethics

  • International Ethical Guidelines for Epidemiological Studies (2008) Council for International Organisations of Medical Sciences (CIOMS) in collaboration with the World Health Organisation, CIOMS, Geneva, Switzerland, February 2008

  • Miller S (2002) Model code of ethical principles. Centre for applied philosophy and public ethics, Charles Sturt University, for the professional standards council of New South Wales and Western Australia, June 2002

  • Morales Pedraza J, Herson MR (2011) The importance of ethic in the field of human tissue banking. Cell Tissue Bank. doi:10.1007/s10561-010-9232-2

  • Nelkin D, Andrews L (1998) Homo economicus: the commercialisation of body tissue in the age of biotechnology. Hastings centre report, New York, USA

  • Oversight of Tissue Banking (2001) Department of Health and Human Services, Office of Inspector General, USA, January 2001

  • Quintana-Trias, Octavi M (1998) Ethical aspects of human tissue. European Commission, July 1998

  • Recommendations REC-RCIDT-2007 (7) and 2008 (8) Ibero-American donation and transplant council. Newsletter 2(1): October 2008

  • Schulz-Baldes A, Biller Andorno N, Morgan Capron A (2007) International perspectives on the ethics and regulation of human cell and tissue transplantation. Institute of Biomedical Ethics, Centre for Ethics, University of Zurich, Zurich, Switzerland and Gould School of Law, University of Southern California, Los Angeles, CA, USA, WHO Bulletin

  • The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2008) International summit on transplant tourism and organ trafficking convened by the transplantation society and international society of nephrology in Istanbul, Turkey, April 30–May 2, 2008

  • The Nuremberg Code (1949) From trials of war criminals before the Nuremberg military tribunals under control council law no 10, vol 2, Nuremberg, October 1946–April 1949, US Government Printing Office, Washington, DC, USA, pp 181–182

  • WHO guiding principles on human cell, tissue and organ transplantation, resolution WHA 63.22, May 2010

Download references

Acknowledgments

I would like to thanks Professor Glyn O. Phillips (UK), Dr. Astrid Lobo Gajiwala (India), and Dr. Saimel Bello Gonzalez (Cuba) for their relevant contributions and support in the preparation of this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge Morales Pedraza.

Appendix 1

Appendix 1

Definitions of terms

Unless otherwise defined in the tissue-specific standards or otherwise used in another context in this Code, the following terms shall be defined as follows:

Allograft: Tissue intended for transplantation into another individual of the same species.

Autograft: Tissue intended for implantation, transplantation or infusion into the individual from whom they were recovered.

Deviation: An event that is a departure from a procedure or normal practice.

Distribution: A process that includes receipt of a request for tissues, selection and inspection of appropriate tissues, and inspection, and subsequent shipment and delivery of tissues to another tissue bank, tissue distribution intermediary or tissue dispensing service.

Donor: A living or deceased individual who is the source of tissues for transplantation in accordance with established medical criteria and procedures.

Informed consent: A procedure whereby information concerning the donation process is presented to the donor or donor’s next of kin with an opportunity for them to ask questions, after which specific approval is documented.

Living donor: A donor whose heart is beating at the time of tissue donation.

Next of kin: The person(s) most closely related to a deceased individual.

Procedure: A series of steps, which when followed, is designed to result in a specific outcome.

Processing: Any activity performed on tissues, other than tissue recovery, including preparation, preservation for storage, and/or removal from storage, to assure the quality and/or sterility of human tissues. Processing includes steps to inactivate and remove adventitious agents.

Procurement: See Retrieval

Quality: The conformance of tissues or a process with pre-established specifications or standards.

Quality control: Specific tests defined by the Quality Assurance Programme to be performed to monitor retrieval, processing, preservation and storage, tissue quality, and test accuracy. These may include but are not limited to, performance evaluations, inspection, testing, and controls used to determine the accuracy and reliability of the tissue bank’s equipment and operational procedures, as well as the monitoring of supplies, reagents, equipment, and facilities.

Recipient: An individual into whom tissues is transplanted.

Recovery: Obtaining tissues from a donor that is intended for use in human transplantation.

Resolution: Adjustment, clarification, and/or correction of practices and/or procedures that results in compliance with the SOPs and/or standards.

Retrieval: The removal, acquisition, recovery, harvesting or collection of donor tissues.

Standard operating procedure: A group of standards detailing the specific policies of a tissue bank and the procedures used by the staff/personnel. This includes but is not limited to, procedures to assess donor suitability, retrieval, processing, quarantine, release to inventory, labeling, storage, distribution, and recalling tissues.

Storage: The maintenance of tissues for future use.

Tissue: A functional group of cells.

Tissue bank: An entity that provides or engages in one or more services involving tissues from living or deceased individuals for transplantation purposes. These services include assessing donor suitability, recovery, processing, storage, labeling, and distribution of tissues.

Transplantation: The transfer of tissue to a recipient. This includes musculoskeletal, skin, cardiovascular, and fetal tissues, as well as reproductive tissues used in assisted reproductive procedures.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morales Pedraza, J. A model of a code of ethics for tissue banks operating in developing countries. Cell Tissue Bank 13, 607–622 (2012). https://doi.org/10.1007/s10561-011-9279-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10561-011-9279-8

Keywords

Navigation